It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LCID’s FA Score shows that 0 FA rating(s) are green whileNVCR’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LCID’s TA Score shows that 6 TA indicator(s) are bullish while NVCR’s TA Score has 6 bullish TA indicator(s).
LCID (@Motor Vehicles) experienced а -1.12% price change this week, while NVCR (@Medical Specialties) price change was +2.96% for the same time period.
The average weekly price growth across all stocks in the @Motor Vehicles industry was +8.62%. For the same industry, the average monthly price growth was +19.16%, and the average quarterly price growth was +10.17%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -0.78%. For the same industry, the average monthly price growth was +5.29%, and the average quarterly price growth was -0.03%.
LCID is expected to report earnings on Aug 11, 2025.
NVCR is expected to report earnings on Jul 24, 2025.
Automobiles continue to be arguably the most popular form of passenger travel in the U.S., and major automobile makers have revenues and market capitalizations running into multi-billions. In recent years, the industry has been experiencing some path-breaking innovations like electric vehicles and self-driving technology. While there are long-standing companies like General Motors, Ford, and Toyota Motors operating in this space, there are also emerging/rapidly growing players like Tesla – which has had a major role in the growing popularity of the electric vehicle market. With technological advancements taking steam in the auto space, we’ve also witnessed collaborations (or talks of potential partnerships) of carmakers with tech behemoths like Google’s subsidiary, Waymo.
@Medical Specialties (-0.78% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
LCID | NVCR | LCID / NVCR | |
Capitalization | 6.55B | 1.66B | 395% |
EBITDA | -2.57B | -177.45M | 1,448% |
Gain YTD | -11.921 | -39.228 | 30% |
P/E Ratio | 10.31 | N/A | - |
Revenue | 595M | 509M | 117% |
Total Cash | 3.86B | 911M | 424% |
Total Debt | 2.43B | 596M | 407% |
NVCR | ||
---|---|---|
OUTLOOK RATING 1..100 | 8 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 100 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 94 | |
PRICE GROWTH RATING 1..100 | 57 | |
P/E GROWTH RATING 1..100 | 7 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LCID | NVCR | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 2 days ago82% | 2 days ago80% |
Momentum ODDS (%) | 2 days ago77% | 2 days ago79% |
MACD ODDS (%) | 2 days ago79% | 2 days ago69% |
TrendWeek ODDS (%) | 2 days ago85% | 2 days ago76% |
TrendMonth ODDS (%) | 2 days ago79% | 2 days ago81% |
Advances ODDS (%) | 10 days ago78% | 4 days ago77% |
Declines ODDS (%) | 2 days ago86% | 10 days ago90% |
BollingerBands ODDS (%) | N/A | 2 days ago81% |
Aroon ODDS (%) | 3 days ago85% | 3 days ago89% |
A.I.dvisor indicates that over the last year, LCID has been loosely correlated with RIVN. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if LCID jumps, then RIVN could also see price increases.
Ticker / NAME | Correlation To LCID | 1D Price Change % | ||
---|---|---|---|---|
LCID | 100% | -3.97% | ||
RIVN - LCID | 61% Loosely correlated | N/A | ||
NIO - LCID | 39% Loosely correlated | N/A | ||
TSLA - LCID | 34% Loosely correlated | N/A | ||
GP - LCID | 34% Loosely correlated | N/A | ||
VWAGY - LCID | 32% Poorly correlated | -0.62% | ||
More |
A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with RVTY. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then RVTY could also see price increases.
Ticker / NAME | Correlation To NVCR | 1D Price Change % | ||
---|---|---|---|---|
NVCR | 100% | +2.03% | ||
RVTY - NVCR | 40% Loosely correlated | +0.72% | ||
TWST - NVCR | 39% Loosely correlated | N/A | ||
AZTA - NVCR | 38% Loosely correlated | +2.00% | ||
ALGN - NVCR | 37% Loosely correlated | +0.41% | ||
BLFS - NVCR | 37% Loosely correlated | N/A | ||
More |